Research & Development
10 June 2026 - US healthcare company Organon (NYSE:OGN) on Wednesday announced US Food and Drug Administration (FDA) approval of a supplemental Biologics License Application for TOFIDENCE (tocilizumab...
9 June 2026 - Biopharmaceutical company GSK plc (LON:GSK) (NYSE:GSK) announced on Tuesday that it has entered an agreement to acquire Nuvalent Inc (NASDAQ:NUVL), a Boston-based clinical-stage biopharm...
9 June 2026 - Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), an Israeli pharmaceutical company, announced on Monday that it has entered into a definitive agreement to acquire Colospan Ltd., an Israeli co...
8 June 2026 - Global biotechnology company Alvotech S.A. (NASDAQ:ALVO) announced on Monday that the US Food and Drug Administration (FDA) has accepted for review its Biologics License Application for ...